Abstract #2956

Investigation of lung cancer early detection with serum MRS biomarkers

Leo Ling Cheng¹, Tjada A. Schult^1,2, Mara J. Lauer^1,3, Lindsey A. Vandergrift¹, Mari A. Mino-Kenudson⁴, and David C. Christiani^5,6

¹Pathology, Massachusetts General Hospital, Charlestown, MA, United States, ²Charite Medical University, Berlin, Germany, ³Julius-Maximilians University, Wuerzburg, Germany, ⁴Pathology, Massachusetts General Hospital, Boston, MA, United States, ⁵Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, United States, ⁶Department of Medicine, Massachusetts General Hospital, Boston, MA, United States

To improve the survival rate of non-small cell lung cancer (LuCa) patients, an economically efficient screening method without radiation hazard is preferred. Based on our previously reported potential serum biomarkers for predicting survival and differentiating LuCa stages and types, we investigated the potential for these biomarkers to be used for early detection screening using LuCa serum samples from patients prior to their diagnoses and compared with those measured at the time of diagnosis. If developed, our findings could be used as a minimally-invasive early diagnosis scheme.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.